Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
---|
01/05/2006 | CA2572153A1 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes |
01/05/2006 | CA2571356A1 Novel hexafluoroisopropanol derivatives |
01/05/2006 | CA2571012A1 Tricyclic compounds and their use as mglur1 antagonists |
01/04/2006 | EP1611091A1 Novel compounds |
01/04/2006 | EP1611090A2 Cannabinoid receptor ligands |
01/04/2006 | EP1611088A2 Hydroxamates as therapeutic agents |
01/04/2006 | EP1610753A2 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
01/04/2006 | CN1717388A Bifunctional phenyliso(thio)cyanates, processes and intermediates products for their preparation |
01/04/2006 | CN1717376A Catalytic hydrogeneration of carbon-heteroatom double bonds |
01/03/2006 | US6982279 Arylated furan- and thiophenecarboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them |
01/03/2006 | US6982263 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases |
01/03/2006 | CA2247451C Carboxylic acid derivatives having fused rings as retinoic acid receptor agonist |
01/03/2006 | CA2244695C Cyclic amic acid derivatives |
01/03/2006 | CA2093577C Alkyl or alkoxy substituted s-heterocyclic retinoids |
12/29/2005 | WO2005123722A1 Heterocyclic carboxamides with microbiocidal activity |
12/29/2005 | WO2005123634A1 Fluorene derivative and organic electroluminescent device using same |
12/29/2005 | WO2005123089A2 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
12/29/2005 | WO2005123065A1 Chemokine receptor antagonistic medicinal composition |
12/29/2005 | WO2005009104A3 Benzoic and phenyl acetic acid derivatives as hnf-4 modulators |
12/29/2005 | US20050288376 Bicyclyl or heterobicyclylmethanesulfonylanimo-substituted N-hydroxyformamides |
12/29/2005 | US20050288324 Aromatic sulfonamides as peroxynitrite-rearrangement catalysts |
12/29/2005 | US20050288282 Anticancer agents; antiproliferative agents |
12/29/2005 | US20050288186 1-(4-{3-[2,6-Dichloro-4-(3,3-dichloro-allyloxy)-phenoxy]-propoxy}-phenyl)-1H-pyrrole, for example; protecting soybean plants against pests such as caterpillars |
12/28/2005 | EP1609785A1 C-glycoside derivatives and salts thereof |
12/28/2005 | EP1608638A1 Fluoro-and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof |
12/28/2005 | EP1608637A1 Trifluoromethyl-thiophene carboxylic acid anilides and use thereof as fungicides |
12/28/2005 | EP1608352A1 Polyamine compounds for treating chemokine receptor mediated diseases |
12/28/2005 | EP1608309A2 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
12/28/2005 | EP1527076B1 Dihydro-dibenzo[b,e]oxepine based selective estrogen receptor modulators, compositions and methods |
12/28/2005 | EP1399416A4 Peptide deformylase inhibitors |
12/28/2005 | EP1299352B1 Compounds to treat alzheimer's disease |
12/28/2005 | EP1084125B1 Condensed thienopyrimidines with phosphodiesterase-v inhibiting action |
12/28/2005 | EP1031563B1 Sulfonyl derivatives |
12/28/2005 | CN1714076A Novel aryl ureido benzoic acid derivatives and their use |
12/28/2005 | CN1714074A Process for producing aromatic nitrile compound |
12/28/2005 | CN1233646C Process of 2-methyl-thiophene benzodinitro heterotropilidene |
12/28/2005 | CN1233621C Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same |
12/27/2005 | CA2305463C Aminobutanoic acid derivatives |
12/27/2005 | CA2290506C 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors |
12/27/2005 | CA2237910C Excitatory amino acid derivatives |
12/27/2005 | CA2160712C Novel 1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular hypotensive agents |
12/22/2005 | WO2005122278A1 Organic semiconductor thin film, organic semiconductor device, organic thin film transistor, and organic electro-luminescence element |
12/22/2005 | WO2005122277A1 Organic thin film transistor |
12/22/2005 | WO2005121134A1 Thiophene derivatives, their manufacture and use as pharmaceutical agents |
12/22/2005 | WO2005121130A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
12/22/2005 | WO2005121120A1 Thiophene hydroxamic acid derivatives and their use as hdac inhibitors |
12/22/2005 | WO2005121119A1 Hydroxamates, their manufacture and use as pharmaceutical agents |
12/22/2005 | WO2005121063A1 Process for forming branched composition catalytically by carbon-hydrogen bond activation in a saturated moiety |
12/22/2005 | WO2005120515A2 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease |
12/22/2005 | WO2005066151A3 Histone deacetylase inhibitors |
12/22/2005 | WO2005061443A3 Benzoyl-substituted phenylalanine amides |
12/22/2005 | US20050282908 Substituted aminopropoxyaryl derivatives useful as agonists for LXR |
12/22/2005 | US20050282899 Resorcinol derivatives |
12/22/2005 | US20050282881 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
12/22/2005 | US20050282872 Novel thyroid receptor ligands and method II |
12/22/2005 | US20050282858 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents |
12/22/2005 | US20050282821 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
12/22/2005 | DE102004027332A1 New organometallic transition metal compound useful as catalyst constituents of catalyst systems for the polymerization of ethylene |
12/22/2005 | CA2569623A1 Novel compounds and use of tetrahydropyridothiophenes |
12/22/2005 | CA2569111A1 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
12/22/2005 | CA2567835A1 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease |
12/22/2005 | CA2566525A1 Thiophene derivatives, their manufacture and use as pharmaceutical agents |
12/22/2005 | CA2566515A1 Thiophene hydroxamic acid derivatives and their use as hdac inhibitors |
12/22/2005 | CA2566512A1 Hydroxamates, their manufacture and use as pharmaceutical agents |
12/21/2005 | EP1606275A1 Opioid receptor antagonists |
12/21/2005 | EP1362039B1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
12/21/2005 | CN1711252A 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
12/21/2005 | CN1711239A Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof |
12/21/2005 | CN1709889A Compound having thio furan and acetylene ethylene bond, its preparation and use |
12/21/2005 | CN1232513C 1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compound, preparation thereof and pharmaceutics containing it |
12/21/2005 | CN1232505C Substituted sulfamide (thio) carbonyl compounds |
12/20/2005 | US6977265 Piperidine CCR-3 receptor antagonists |
12/20/2005 | CA2273303C Thienylsulfonylamino(thio)carbonyl compounds |
12/20/2005 | CA2181569C Ep2-receptor agonists as agents for lowering intraocular pressure |
12/15/2005 | WO2005119315A2 Non-linear optically active molecules, their synthesis, and use |
12/15/2005 | WO2005118654A1 Transition metal compound, ligand system, catalyst system and process for preparing polyolefins |
12/15/2005 | WO2005117907A2 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions |
12/15/2005 | WO2005117590A2 Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
12/15/2005 | US20050277665 e.g. 1,1,1-trifluoro-2-[4-(toluene-2-sulfonyl)phenyl]-propan-2-ol; hydroxysteroid dehydrogenases inhibitor; interconversion between cortisone and cortisol in humans; antidiabetic agent; obesity, insulin resistance, non-insulin -dependent diabetes |
12/15/2005 | US20050276754 Bridged aromatic substituted amine ligands with donor atoms |
12/15/2005 | US20050274954 Organic thin film transistor |
12/15/2005 | CA2568639A1 Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
12/15/2005 | CA2565705A1 Non-linear optically active molecules, their synthesis, and use |
12/14/2005 | EP1605733A1 Conjugate molecule, electroluminescent element using the same and electronic apparatus using the electroluminescent element |
12/14/2005 | EP1603914A1 Compounds having activity at 5ht2c receptor and uses thereof |
12/14/2005 | EP1603858A2 Kcnq channel modulating compounds and their pharmaceutical use |
12/14/2005 | EP1066258B1 Aryl phenyl substituted cyclic ketoenols |
12/14/2005 | CN1708496A Cyclopropyl-thienyl-carboxamide as fungicides |
12/14/2005 | CN1708479A Novel compounds useful in treating PPAR mediated diseases |
12/14/2005 | CN1708478A P-(sulfonyl)-aryl and heteroaryls amines |
12/14/2005 | CN1708476A Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds |
12/14/2005 | CN1706839A Non-benzenoid aryl spiro material and its synthesis and application |
12/14/2005 | CN1231487C Metallocenes and catalysts for olefin-polymerisation |
12/14/2005 | CN1231465C Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament |
12/14/2005 | CN1231440C Novel tricyclic compound |
12/14/2005 | CN1231431C Process for preparing substituted 2-3-dihydro-1-indanones |
12/08/2005 | WO2005116198A2 Methods of 1,3-enyne preparation using copper (i) catalysts |
12/08/2005 | WO2005116010A1 Ep4 receptor agonist, compositions and methods thereof |
12/08/2005 | WO2005097100A3 Antibacterial agents |
12/08/2005 | WO2005082350A8 Furosemide derivatives as modulators of hm74 and their use for the treatment of inflammation |